Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-09-09EMA Authorised: Zinforo (ceftaroline fosamil) — Pfizer Ireland Pharmaceuticals
The EMA authorised Zinforo (ceftaroline fosamil) for community-acquired infections, including pneumonia and skin and soft tissue infections,…
-
FDA approval · 2025-08-06FDA Approved: TIGECYCLINE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for tigecycline from Apotex Corp, indicating an approved addition or update under the supplemental f…
-
EMA approval · 2025-04-29EMA Authorised: Xenleta (lefamulin acetate) — Nabriva Therapeutics Ireland DAC
The European Medicines Agency authorised Xenleta (lefamulin acetate) for treatment of community-acquired pneumonia, expanding options for ba…
-
FDA approval · 2024-12-04FDA Approved: DOXYCYCLINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's generic doxycycline as an original ANDA product.
-
FDA approval · 2024-10-28FDA Approved: DOXYCYCLINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic doxycycline as an Original Application (ANDA 218053), enabling market entry of a doxycycl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-10FDA Approved: LINEZOLID — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for LINEZOLID (linezolid), making a generic linezolid available in the U.S. fo…
-
FDA approval · 2024-08-22FDA Approved: LINEZOLID — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for LINEZOLID (linezolid); the approval finalizes changes to the …
-
FDA approval · 2024-06-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved gener…
-
FDA approval · 2024-06-13FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Ertapenem (ERTAPENEM) by Eugia US LLC. The action relates to a modification/expansion of the dru…
-
FDA approval · 2024-05-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizin…
-
FDA approval · 2023-12-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approved an Original Application for amoxicillin and clavulanate potassium (amoxicillin/clavulanate) as a generic antibiotic formulation…
-
FDA approval · 2023-09-15FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approves a generic amoxicillin/clavulanate potassium product under an Original Application by Devatis, Inc.
-
FDA approval · 2023-09-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis Inc.)
FDA approved a generic Amoxicillin and clavulanate potassium product under Original Application by Devatis Inc.
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for clarithromycin, marking a supplemental approval for this generic antibiotic. The acti…
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic version of clarithromycin produced by Lannett Company, Inc.
-
FDA approval · 2023-01-27FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for ertapenem submitted by Eugia US LLC, authorizing changes to its approved labeling and/or ind…
-
FDA approval · 2022-12-07FDA Approved: DOXYCYCLINE — Original Application (Par Health USA, LLC)
FDA approved a generic doxycycline product under an original new drug application by Par Health USA, LLC (ANDA216690).
-
FDA approval · 2022-11-02FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium submitted by USAntibiotics, LLC.
-
FDA approval · 2022-10-31FDA Approved: LINEZOLID — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' LINEZOLID generic under an Original Abbreviated New Drug Application (ANDA 211813). The approval covers…
-
FDA approval · 2022-02-08FDA Approved: ERTAPENEM — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Apotex Corp to market ertapenem sodium (ERTAPENEM) as a generic antibiotic.
-
FDA approval · 2022-01-31FDA Approved: CLARITHROMYCIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic clarithromycin under Original Application ANDA210459. This expands access to clarithromycin as…
-
FDA approval · 2022-01-12FDA Approved: AZITHROMYCIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for AZITHROMYCIN submitted by Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2021-09-21FDA Approved: CEFTAROLINE FOSAMIL — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s original application for ceftaroline fosamil, making a generic ceftaroline fosamil available in the United S…
-
FDA approval · 2021-07-29FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to allow Zosyn (piperacillin/tazobactam) to be supplied in Galaxy containers, by Wyeth Pharmaceutica…
-
FDA approval · 2021-02-19FDA Approved: CEFDINIR — Original Application (American Health Packaging)
FDA approves the original ANDA for cefdinir (CEFDINIR) by American Health Packaging, making a generic cefdinir product available.